About
Sorrento Therapeutics is a clinical-stage biopharmaceutical company developing antibody, cell therapy, and small molecule treatments focused on cancer, pain management, and inflammatory diseases.
Explore Sorrento Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.